Hagonay, Mery Jane B.

HRN: 20-92-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
CEFTRIAXONE 1G (VIAL)
06/18/2022
06/24/2022
IV
2g
OD
CAP MR
Waiting Final Action 
06/18/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/18/2022
06/22/2022
PO
500mg
OD
CAP MR
Waiting Final Action 
06/24/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/24/2022
06/30/2022
IV
1.5g
Q6
CTscan: Loculated Pleural Eff R; Bilateral Pneumonia
Waiting Final Action 
06/27/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/27/2022
07/03/2022
IVTT
4.5g LD; 2.25g
Q8
Pulmonary Infiltrates With Pleural Effusion

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: